March 28th 2023
Toripalimab plus bevacizumab and platinum-based chemotherapy produces a “promising” response rate in those with metastatic cervical cancer, according to an expert from Peking Union Medical College.
Some Older Women Still Need Cervical Cancer Screening
May 17th 2017The number of women who undergo regular screening for cervical cancer drops as they get older, and while this is acceptable if women have been followed regularly until the age of 65 years, women who are not up to date with screening should be screened when they are older.
Sexual and urinary morbidities resulting from treatment of pelvic malignancies are common. Awareness of these complications is critical in order to properly counsel patients regarding potential side effects and to facilitate prompt diagnosis and management.
HIV Infection Decreases Survival in Women With Invasive Cervical Cancer
August 30th 2016HIV infection significantly decreases survival among women with invasive cervical cancer, according to a study conducted in Botswana. This was the case even though most women with HIV received antiretroviral therapy.
Cisplatin/Paclitaxel Plus RT Offers Good Results in Advanced Cervical Cancer
June 22nd 2016A concurrent chemotherapy and radiotherapy regimen with cisplatin and paclitaxel yielded a good response rate and strong long-term survival outcomes in patients with locally advanced or recurrent cervical cancer.
AXAL Immunotherapy Well-Tolerated in Recurrent Metastatic Cervical Cancer
June 16th 2016A live attenuated bioengineered bacteria-vectored vaccine immunotherapy is well tolerated and appears to be associated with promising overall survival among women with persistent/recurrent metastatic cervical cancer.
ASCO Releases Resource-Stratified Invasive Cervical Cancer Guidelines
May 25th 2016ASCO has released a clinical practice guideline on invasive cervical cancer. For the first time, ASCO created the guideline based on resource availability, tailoring recommendations to support basic- or limited-resource settings.
Uptick in HPV Vaccinations Highest in Hispanic, High Poverty Communities
January 15th 2016Adolescent girls who live in predominantly Hispanic and high poverty communities are more likely to have had at least one HPV vaccine dose compared to girls in low poverty communities and those with different ethnic make up.
Questions We Should Be Asking About Bevacizumab for Cervical Cancer
May 15th 2015There is good evidence that angiogenesis plays a central role in cervical cancer pathogenesis, suggesting a strong rationale for adding anti-angiogenesis agents to chemotherapeutic agents for the treatment of this disease.